Transcatheter aortic valve implantation (TAVI) is the optimal type of treatment of elderly patients with aortic stenosis with a high risk of mortality during traditional surgical correction of the defect.

Aortic valve replacement is the main treatment for aortic stenosis – a partial narrowing of the lumen of the aortic valve, causing difficulty in the outflow of blood from the left ventricle of the heart into the aorta, which supplies blood to the entire body.

Endovascular aortic valve replacement is used in cases where standard “open” surgery is associated with high surgical risks. This operation is indicated for patients with aortic disease who suffer from severe concomitant diseases: vascular lesions, chronic diseases of the lungs, liver, endocrine pathology, oncology.

In this case, the replacement of the aortic valve is performed without large surgical incisions through a puncture of the femoral artery under X-ray control, without artificial circulation and general anesthesia. One of the advantages of this technology is to reduce the side effects of sternotomy (sternum dissection): blood loss, pain intensity during the patient’s stay in the hospital, and the risk of infection associated with a postoperative suture. The use of endovascular technologies significantly shortens the rehabilitation period of patients.